2011
DOI: 10.1016/j.exppara.2010.11.010
|View full text |Cite
|
Sign up to set email alerts
|

Leishmania chagasi: Effect of the iron deficiency on the infection in BALB/c mice

Abstract: Iron deficiency and visceral leishmaniasis are serious problems of public health. The aim of this study was to evaluate the effect of iron deficiency, induced by the iron chelator desferrioxamine, on the course of the infection by Leishmania chagasi in BALB/c mice. Our data show that the iron chelator caused significant reduction in hemoglobin concentration of treated mice and reduction in parasite load in spleen and liver. Significant differences were not observed in the production of IFN-gamma and IL-4 among… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 15 publications
1
14
0
Order By: Relevance
“…Observations regarding the effects of iron chelators on Leishmania growth are conflicting. Treatment of mice with desferrioxamine (DFO) led to the decrease of L. infantum proliferation [57] but not that of L. major [12]. Also, in in vitro models of macrophage infection, DFO has shown either no effect [58] or an inhibitory effect [59], [60], [61] on Leishmania growth.…”
Section: Discussionmentioning
confidence: 99%
“…Observations regarding the effects of iron chelators on Leishmania growth are conflicting. Treatment of mice with desferrioxamine (DFO) led to the decrease of L. infantum proliferation [57] but not that of L. major [12]. Also, in in vitro models of macrophage infection, DFO has shown either no effect [58] or an inhibitory effect [59], [60], [61] on Leishmania growth.…”
Section: Discussionmentioning
confidence: 99%
“…Manipulation of host iron status through the use of chelators or supplemental iron has produce conflicting outcomes. For example, treatment of mice with desferroxamine for 2 weeks resulted in reduced L. chagasi burden in both the liver and spleen [116]. In contrast, parenteral iron supplementation protected mice against Leishmania major, however this outcome appears to be the result of an enhanced immune response as the oxidative burst was enhanced in the iron treated animals [117].…”
Section: Global Diseases Influenced By Iron Statusmentioning
confidence: 99%
“…However, DFO has shown either no effect (Murray et al, 1991) or an inhibitory effect on the intramacrophagic growth of L. donovani (Segovia et al, 1989; Das et al, 2009) and L. amazonensis (Borges et al, 1998). Moreover, treatment of mice with DFO does not affect the development of skin lesions caused by L. major (Bisti et al, 2000), but reduces the hepatic and splenic growth of L. infantum (Malafaia et al, 2011). Conversely, feeding mice with an iron-deficient diet did not influence L. infantum proliferation (Vale-Costa et al, 2013).…”
Section: Iron Metabolism In Leishmania Infectionmentioning
confidence: 99%